BSX
Boston Scientific Corporation
Boston Scientific Corporation is a medical device manufacturer with heavy political exposure evidenced by $61.4M in annual physician payments, $87.3M in federal contracts, and 8 politicians trading its stock while lobbying on healthcare issues.
Govt Dependence
65/100
Regulatory Density
85/100
Lobbying Intensity
60/100
Political Signal
BULLISH
BusinessWhat BSX does
Boston Scientific Corporation develops, manufactures, and markets medical devices for interventional medical specialties. Its revenue lines include products for cardiology, endoscopy, urology, and neuromodulation. The business model relies on physician adoption, Medicare/Medicaid reimbursement, and FDA regulatory pathways for new devices.
12 months past · 3 months futureBSX activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
240 trading days ·
28 congressional trades shown
·
0 insider buys
·
15 13F filings
·
0 past bill actions
·
16 upcoming markups
Executive Branch ConflictsBSX held by Trump-administration officials
2 cabinet/senior officials reported BSX positions in OGE Form 278 disclosures across 2 filings.
Lifetime Government AwardsBSX federal contracts by year
$87M
total awarded · 2015–2026
494
contracts on file
2022
peak year ($21M)
Top contracts by award amount
$4.7M
Department of Defense
2019-09-01
THERASPHERE
$4.0M
Department of Veterans Affairs
2022-04-23
Y90 GLASS MICROSPHERES
$2.9M
Department of Veterans Affairs
2022-10-01
THERASPHERE Y-90 GLASS MICROSPHERE MEDICATION
$1.7M
Department of Veterans Affairs
2022-01-01
EXPRESS REPORT: BOSTON SCIENTIFIC CONSIGNMENT AGREEMENT EXPENDITURES.
$1.4M
Department of Veterans Affairs
2021-04-01
YTTRIUM-90 THERASPHERES
12 years · 494 contracts
Smart Money · 13F HoldingsHedge funds holding BSX
$11.27B
Total BSX held by tracked 13F funds
40
Funds with BSX positions
+40
Funds opened this quarter
Citadel Advisors
$953M
opened
2024-06-30
D.E. Shaw & Co.
$856M
opened
20 overlap
2025-12-31
Citadel Advisors
$812M
opened
2024-09-30
D.E. Shaw & Co.
$734M
opened
2025-09-30
Citadel Advisors
$692M
opened
2025-09-30
D.E. Shaw & Co.
$665M
opened
2025-06-30
Citadel Advisors
$585M
opened
2024-03-31
Citadel Advisors
$562M
opened
2025-06-30
32 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading BSXMembers of Congress with recent BSX positions
10 politicians traded BSX across 62 disclosed transactions totaling $668K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just BSX). 0-30 LOW · 30-60 MID · 60+ HIGH.
Ro Khanna
8 buys
7 sells
$169K
2026-03-30
LOW · 0
Gilbert Ray Cisneros
5 buys
15 sells
$160K
2026-02-10
HIGH · 61
Lisa C. McClain
4 buys
6 sells
$80K
2025-10-31
LOW · 0
Jefferson Shreve
2 sells
$65K
2025-05-12
LOW · 0
Kevin Hern
2 sells
$65K
2025-10-28
LOW · 1
Markwayne Mullin
1 buy
$33K
2025-12-29
LOW · 29
Bruce Westerman
2 buys
2 sells
$32K
2025-04-21
LOW · 0
Val T. Hoyle
2 buys
2 sells
$32K
2025-09-23
LOW · 0
John Boozman
2 buys
1 sell
$24K
2025-12-17
MID · 47
Michael T. McCaul
1 buy
$8K
2026-03-27
LOW · 0
Congressional TradesWho in Congress is trading BSX
2026-03-27
Michael T. McCaul
Purchase
$1,001 - $15,000
2026-03-30
Ro Khanna
Purchase
$15,001 - $50,000
2026-02-10
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-01-30
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-01-29
Ro Khanna
Purchase
$15,001 - $50,000
2026-01-06
Ro Khanna
Sale
$1,001 - $15,000
2025-12-29
Markwayne Mullin
Purchase
$15,001 - $50,000
2025-12-17
John Boozman
Sale (Partial)
$1,001 - $15,000
2025-12-24
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2025-11-18
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2025-10-31
Lisa C. McClain
sale
$1,001 - $15,000
2025-10-31
Lisa C. McClain
Sale
$1,001 - $15,000
30+ trades on file · most recent 2026-04-10
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
10
stock awards · $31.0M market value
2026-03-02
Weber Christophe Pierre
Director
AWARD
323 sh
$25K
2026-03-02
Morano Susan E
Director
AWARD
24 sh
$2K
2026-02-13
Mahoney Michael F
Chairman, President & CEO
AWARD
132,190 sh
$9.9M
2026-02-13
Mahoney Michael F
Chairman, President & CEO
AWARD
132,190 sh
$9.9M
2026-02-13
Fitzgerald Joseph Michael
EVP & Group Pres, Cardiology
AWARD
34,898 sh
$2.6M
2026-02-13
Fitzgerald Joseph Michael
EVP & Group Pres, Cardiology
AWARD
34,898 sh
$2.6M
2026-02-13
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
AWARD
25,380 sh
$1.9M
2026-02-13
Butcher Arthur C
EVP& Grp Pres, MedSurg & APAC
AWARD
25,380 sh
$1.9M
For BSX, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting BSXLive legislation impacting this stock
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HR.1784 · 119th
Medicare Fraud Detection and Deterrence Act of 2025
HR.1776 · 119th
New Health Options Act of 2025
HRES.182 · 119th
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
HR.1806 · 119th
Triple-Negative Breast Cancer Research and Education Act of 2025
S.786 · 119th
Public Health Funding Restoration Act
S.763 · 119th
Telehealth Expansion Act of 2025
HR.920 · 119th
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
SRES.90 · 118th
A resolution recognizing the significance of endometriosis as an unmet chronic disease for women and designating March 2023 as "En
S.606 · 118th
Protecting Americans from Dangerous Opioids Act
Political ProfileWhere BSX sits in Washington
[object Object]
STRUCTURAL: Strong committee alignment (3 politicians on key health appropriations/authorizing committees) and intense focus on FDA/CMS regulatory lobbying. EVIDENTIARY: High volume of congressional trading (8 politicians, 10+ trades in last year per `top_congressional_traders`), $61.4M in annual physician payments (`get_political_influence.doctor_payments`), and $87.3M federal contract footprint (`get_government_precedent.federal_contracts_summary`). Net: Evidentiary signals (trades, payments) outweigh neutral structural lobbying spend ($0 reported income).
Regulatory ExposureThreats & opportunities
Regulatory threats
-
CMS proposed updates to labor inputs in Physician Fee Schedule impacting reimbursement for high-supply-cost devices.Centers for Medicare & Medicaid Services (CMS)"Cited in `lobbying_filings[0].specific_issues` as 'unintended consequences'."
-
FDA medical device user fee increases and potential new cybersecurity or shortage reporting mandates.Food and Drug Administration (FDA)"`lobbying_filings[0].specific_issues` mentions 'MDUFA, riders & device shortages'."
Regulatory opportunities
-
Establishment of a Transitional Coverage of Emerging Technologies (TCET) pathway for automatic Medicare coverage of Breakthrough devices.Centers for Medicare & Medicaid Services (CMS)"`lobbying_filings[0].specific_issues` shows advocacy for 'voluntary TCET pathway'."
-
Legislation for automatic CMS coverage for devices approved via FDA's Breakthrough pathway.FDA/CMS"`lobbying_filings[0].specific_issues` lists 'Breakthrough Pathway' legislation as a top issue."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for BSX
BOSTON SCIENTIFIC CORPORATION healthcare
Member intelligence layer
Live signals + predictions for BSX — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades BSX
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout BSX & political exposure
Does Boston Scientific Corporation (BSX) hold federal contracts?
Yes. Boston Scientific Corporation has 494 federal contract awards totaling $87,334,921, primarily from agencies including Department of Defense, Department of Health and Human Services, Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own BSX stock?
2 Trump cabinet members or senior White House staff have disclosed holdings in BSX on their OGE 278 financial disclosures, including Donald J. Trump, Lori Chavez-DeRemer. See the Cabinet Conflicts panel for details.
Has Congress traded BSX stock?
336 congressional trades by 22 unique members of Congress, most recently on 2026-03-30. See the Congressional Trading panel for politician-by-politician breakdown.
What is BSX political risk profile?
Government dependence: 65/100. Lobbying intensity: 60/100. Political signal: bullish. Donor party split: R 0% / D 0%.
How does GovGreed track BSX political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. BSX data is updated daily from these official federal sources.